DURATA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Durata Therapeutics Inc. (DRTX) over the Propos...
06 Octubre 2014 - 6:15PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Durata Therapeutics Inc. (DRTX)
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a
leading national securities firm headquartered in New York City, is
investigating the Board of Directors of Durata Therapeutics Inc.
(“Durata” or the “Company”) (NasdaqGM:DRTX) for potential breaches
of fiduciary duties in connection with the sale of the Company to
Actavis plc for approximately $675 million. The Company’s
stockholders will only receive $23.00 for each share of Durata
common stock they own, when according to Yahoo! Finance at least
one analyst has set a price target of $26.00 for the Company. The
deal price might be $5.00 higher based on a contingency-milestone
basis.
Click here for more information:
www.faruqilaw.com/DRTX. There is no cost or
obligation to you.
The investigation focuses on whether Durata’s Board of Directors
breached their fiduciary duties to the Company’s stockholders by
failing to conduct a fair sales process and whether and by how much
this proposed transaction undervalues the Company to the detriment
of Durata’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients. To keep track of the latest
securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
If you own common stock in Durata and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/DRTX or contact Juan E. Monteverde,
Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone
at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Faruqi & Faruqi, LLP369 Lexington Avenue, 10th FloorNew
York, NY 10017Attn: Juan E. Monteverde,
Esq.jmonteverde@faruqilaw.comToll Free: 877-247-4292Phone:
212-983-9330
(MM) (NASDAQ:DRTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
(MM) (NASDAQ:DRTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024